These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35397466)

  • 1. Mutation in Eth A protein of Mycobacterium tuberculosis conferred drug tolerance against enthinoamide in Mycobacterium smegmatis mc
    Anand PK; Kumar A; Saini A; Kaur J
    Comput Biol Chem; 2022 Jun; 98():107677. PubMed ID: 35397466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
    Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
    Vilchèze C; Jacobs WR
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0014-2013. PubMed ID: 26104204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites.
    Laborde J; Deraeve C; Duhayon C; Pratviel G; Bernardes-Génisson V
    Org Biomol Chem; 2016 Sep; 14(37):8848-8858. PubMed ID: 27714216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
    Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 2011 Jan; 55(1):355-60. PubMed ID: 20974869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis.
    Hicks ND; Carey AF; Yang J; Zhao Y; Fortune SM
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation.
    Wang XD; Gu J; Wang T; Bi LJ; Zhang ZP; Cui ZQ; Wei HP; Deng JY; Zhang XE
    Mol Microbiol; 2011 Dec; 82(6):1375-91. PubMed ID: 22026918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator.
    Engohang-Ndong J; Baillat D; Aumercier M; Bellefontaine F; Besra GS; Locht C; Baulard AR
    Mol Microbiol; 2004 Jan; 51(1):175-88. PubMed ID: 14651620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.
    Vilchèze C; Weisbrod TR; Chen B; Kremer L; Hazbón MH; Wang F; Alland D; Sacchettini JC; Jacobs WR
    Antimicrob Agents Chemother; 2005 Feb; 49(2):708-20. PubMed ID: 15673755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the pro-drug ethionamide is regulated in mycobacteria.
    Baulard AR; Betts JC; Engohang-Ndong J; Quan S; McAdam RA; Brennan PJ; Locht C; Besra GS
    J Biol Chem; 2000 Sep; 275(36):28326-31. PubMed ID: 10869356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.
    Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.
    Larsen MH; Vilchèze C; Kremer L; Besra GS; Parsons L; Salfinger M; Heifets L; Hazbon MH; Alland D; Sacchettini JC; Jacobs WR
    Mol Microbiol; 2002 Oct; 46(2):453-66. PubMed ID: 12406221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa.
    Malinga L; Brand J; Jansen van Rensburg C; Cassell G; van der Walt M
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S36-S37. PubMed ID: 28043598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates.
    da Silva DA; Ferreira NV; Rego AM; Barbosa PCP; Machado RF; Pimentel A; Dos Reis LM; de Pina LC; Redner P; Caldas PCS; Fandinho-Montes FCO; Borga L; Leite SP; da Rocha JL; Bastos LS; Ramos JP; Degrave WM; Antunes LCM; Galvão TC
    Tuberculosis (Edinb); 2018 Dec; 113():163-174. PubMed ID: 30514498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
    de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis.
    Xu X; Vilchèze C; Av-Gay Y; Gómez-Velasco A; Jacobs WR
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3133-9. PubMed ID: 21502624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EthA/R-Independent Killing of
    Ang MLT; Zainul Rahim SZ; de Sessions PF; Lin W; Koh V; Pethe K; Hibberd ML; Alonso S
    Front Microbiol; 2017; 8():710. PubMed ID: 28487681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the antituberculosis drug ethionamide.
    Vale N; Gomes P; Santos HA
    Curr Drug Metab; 2013 Jan; 14(1):151-8. PubMed ID: 23215813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.